Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$98.98 - $115.74 $45,530 - $53,240
460 Added 6.65%
7,381 $853,000
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $91,137 - $106,311
-946 Reduced 12.02%
6,921 $711,000
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $844,286 - $892,904
7,867 New
7,867 $858,000
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $476,898 - $685,318
8,094 New
8,094 $501,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.